JP2007515949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007515949A5 JP2007515949A5 JP2006539632A JP2006539632A JP2007515949A5 JP 2007515949 A5 JP2007515949 A5 JP 2007515949A5 JP 2006539632 A JP2006539632 A JP 2006539632A JP 2006539632 A JP2006539632 A JP 2006539632A JP 2007515949 A5 JP2007515949 A5 JP 2007515949A5
- Authority
- JP
- Japan
- Prior art keywords
- tgf
- antagonist
- cancer
- tumor
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52039803P | 2003-11-13 | 2003-11-13 | |
| US55795104P | 2004-03-31 | 2004-03-31 | |
| PCT/US2004/036651 WO2005050200A2 (en) | 2003-11-13 | 2004-11-04 | Screening assays and methods of tumor treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007515949A JP2007515949A (ja) | 2007-06-21 |
| JP2007515949A5 true JP2007515949A5 (https=) | 2007-12-20 |
Family
ID=34623132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006539632A Withdrawn JP2007515949A (ja) | 2003-11-13 | 2004-11-04 | スクリーニングアッセイ及び腫瘍治療の方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060015952A1 (https=) |
| EP (1) | EP1682890A2 (https=) |
| JP (1) | JP2007515949A (https=) |
| KR (1) | KR20060127409A (https=) |
| AR (1) | AR046832A1 (https=) |
| AU (1) | AU2004292180A1 (https=) |
| BR (1) | BRPI0416305A (https=) |
| CA (1) | CA2542215A1 (https=) |
| IL (1) | IL174916A0 (https=) |
| NO (1) | NO20062715L (https=) |
| RU (1) | RU2006120483A (https=) |
| TW (1) | TW200526957A (https=) |
| WO (1) | WO2005050200A2 (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7649013B2 (en) * | 2003-11-26 | 2010-01-19 | Arqule, Inc. | Methods of protecting against radiation injury |
| EP1740615B1 (en) * | 2004-03-31 | 2014-11-05 | Genentech, Inc. | Humanized anti-tgf-beta antibodies |
| US7412026B2 (en) * | 2004-07-02 | 2008-08-12 | The Board Of Regents Of The University Of Oklahoma | Phase-contrast x-ray imaging systems and methods |
| US7853626B2 (en) | 2006-09-29 | 2010-12-14 | The Invention Science Fund I, Llc | Computational systems for biomedical data |
| US10546652B2 (en) * | 2006-09-29 | 2020-01-28 | Gearbox Llc | Computational systems for biomedical data |
| US20080082583A1 (en) * | 2006-09-29 | 2008-04-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems for biomedical data |
| US20080082359A1 (en) * | 2006-09-29 | 2008-04-03 | Searete Llc, A Limited Liability Corporation Of State Of Delaware | Computational systems for biomedical data |
| US20080082367A1 (en) * | 2006-09-29 | 2008-04-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems for biomedical data |
| US10095836B2 (en) * | 2006-09-29 | 2018-10-09 | Gearbox Llc | Computational systems for biomedical data |
| US10503872B2 (en) | 2006-09-29 | 2019-12-10 | Gearbox Llc | Computational systems for biomedical data |
| US10068303B2 (en) | 2006-09-29 | 2018-09-04 | Gearbox Llc | Computational systems for biomedical data |
| US8122073B2 (en) | 2006-09-29 | 2012-02-21 | The Invention Science Fund I | Computational systems for biomedical data |
| US20080091730A1 (en) * | 2006-09-29 | 2008-04-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems for biomedical data |
| US20080109484A1 (en) * | 2006-09-29 | 2008-05-08 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems for biomedical data |
| US8491890B2 (en) * | 2008-07-09 | 2013-07-23 | Board Of Regents Of The University Of Nebraska | Methods and compositions for inhibiting diseases of the central nervous system |
| BRPI0923155A2 (pt) | 2008-12-05 | 2018-10-23 | Abraxis Bioscience Llc | scfcs de ligação a sparc |
| WO2010124276A2 (en) | 2009-04-24 | 2010-10-28 | Vanderbilt Universtiy | Anti-tgf-beta induction of bone cell function and bone growth |
| US8476246B2 (en) * | 2009-07-30 | 2013-07-02 | Antisense Pharma Gmbh | Combination of a chemotherapeutic agent and an inhibitor of the TGF-beta system |
| US20120208209A1 (en) * | 2009-10-30 | 2012-08-16 | Marina Ichetovkin | Pcsk9 immunoassay |
| SI2835053T1 (sl) | 2010-03-12 | 2016-09-30 | Genzyme Corporation | Kombinirana terapija za zdravljenje raka dojke |
| WO2013054320A1 (en) | 2011-10-11 | 2013-04-18 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) |
| US12156912B2 (en) | 2012-05-18 | 2024-12-03 | Board Of Regents Of The University Of Nebraska | Methods and compositions for inhibiting diseases of the central nervous system |
| KR101479543B1 (ko) * | 2013-03-15 | 2015-01-07 | 서강대학교산학협력단 | Ｔｆｇ－ｔｅｃ 융합 컨스트럭트를 이용한 종양 질환의 예방 또는 치료용 물질의 스크리닝 방법 및 이의 용도 |
| US10550196B2 (en) | 2014-04-27 | 2020-02-04 | Famewave Ltd. | Humanized antibodies against CEACAM1 |
| US11427647B2 (en) | 2014-04-27 | 2022-08-30 | Famewave Ltd. | Polynucleotides encoding humanized antibodies against CEACAM1 |
| EP3234120B1 (en) | 2014-12-15 | 2025-09-03 | The Regents of the University of California | Cytotoxic molecules responsive to intracellular ligands for selective t cell mediated killing |
| FI3240805T3 (fi) | 2014-12-15 | 2025-02-17 | Univ California | Cd19- ja cd20-vasteellinen bispesifinen tai-veräjän kimeerinen antigeenireseptori |
| AU2016331081B2 (en) | 2015-10-02 | 2021-04-29 | Wake Forest University Health Sciences | Methods and apparatus for modeling cancer metastasis in vitro |
| PL3368571T3 (pl) * | 2015-10-30 | 2023-05-02 | The Regents Of The University Of California | Polipeptydy odpowiadające na transformujący czynnik wzrostu beta i sposoby ich zastosowania |
| US9758786B2 (en) | 2016-02-09 | 2017-09-12 | Autotelic, Llc | Compositions and methods for treating pancreatic cancer |
| US12038432B2 (en) | 2018-02-02 | 2024-07-16 | Wake Forest University Health Sciences | Organoids related to immunotherapy and methods of preparing and using the same |
| CN112566936B (zh) | 2018-08-21 | 2024-07-12 | 阿尔伯特爱因斯坦医学院 | 针对人tim-3的单克隆抗体 |
| WO2020124084A1 (en) * | 2018-12-15 | 2020-06-18 | The Brigham And Women's Hospital, Inc. | Augmented digital microscopy for lesion analysis |
| CN111088227A (zh) * | 2019-12-31 | 2020-05-01 | 广州航华生物医药科技有限公司 | 一种细胞分离培养液和t细胞分离培养的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000001410A1 (en) * | 1998-07-06 | 2000-01-13 | Beth Israel Deaconess Medical Center | Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis |
| WO2001057061A1 (en) * | 2000-02-04 | 2001-08-09 | California Pacific Medical Center Research Institute | Novel use of ribozymes to block gene expression |
| US20010046502A1 (en) * | 2000-02-04 | 2001-11-29 | The Board Of Trustees Of The University Of Illinois | Animal model for testing immunotherapies of spontaneous metastatic disease |
| CA2298737A1 (en) * | 2000-02-10 | 2001-08-10 | Manikkam Suthanthiran | 2167334tgf-.beta. antagonists to inhibit tumor cell formation or progression |
| US6632979B2 (en) * | 2000-03-16 | 2003-10-14 | Genentech, Inc. | Rodent HER2 tumor model |
| US6767541B2 (en) * | 2000-03-20 | 2004-07-27 | The Regents Of The University Of California | HER-2/neu overexpression abrogates growth inhibitory pathways |
| US20030125251A1 (en) * | 2001-06-21 | 2003-07-03 | Wakefield Lalage M. | Transforming growth factor beta (TGF-beta) antagonist selectively neutralizes "pathological" TGF-beta |
-
2004
- 2004-11-04 WO PCT/US2004/036651 patent/WO2005050200A2/en not_active Ceased
- 2004-11-04 CA CA002542215A patent/CA2542215A1/en not_active Abandoned
- 2004-11-04 US US10/981,356 patent/US20060015952A1/en not_active Abandoned
- 2004-11-04 AU AU2004292180A patent/AU2004292180A1/en not_active Abandoned
- 2004-11-04 EP EP04810283A patent/EP1682890A2/en not_active Withdrawn
- 2004-11-04 BR BRPI0416305-2A patent/BRPI0416305A/pt not_active IP Right Cessation
- 2004-11-04 RU RU2006120483/15A patent/RU2006120483A/ru not_active Application Discontinuation
- 2004-11-04 JP JP2006539632A patent/JP2007515949A/ja not_active Withdrawn
- 2004-11-04 KR KR1020067011504A patent/KR20060127409A/ko not_active Withdrawn
- 2004-11-05 AR ARP040104077A patent/AR046832A1/es unknown
- 2004-11-05 TW TW093133935A patent/TW200526957A/zh unknown
-
2006
- 2006-04-10 IL IL174916A patent/IL174916A0/en unknown
- 2006-06-12 NO NO20062715A patent/NO20062715L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007515949A5 (https=) | ||
| Halvorson et al. | A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone | |
| RU2006120483A (ru) | Скрининг-анализы и способы лечения опухоли | |
| Ta et al. | Osteosarcoma treatment: state of the art | |
| Abdollahi et al. | Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis | |
| Higo et al. | Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy | |
| Kim et al. | Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer | |
| Kuefner et al. | DNA double-strand breaks and their repair in blood lymphocytes of patients undergoing angiographic procedures | |
| Xiao et al. | Postoperative tumor treatment strategies: From basic research to clinical therapy | |
| WO2018067545A1 (en) | Chondroprotective nanoparticles for the treatment of osteoarthritis | |
| AU2017214230A1 (en) | Copanlisib biomarkers | |
| Terashima et al. | Beneficial effect of maintaining hepatic reserve during chemotherapy on the outcomes of patients with hepatocellular carcinoma | |
| Hayat | Brain metastases from primary tumors, volume 3: epidemiology, biology, and therapy of melanoma and other cancers | |
| Wang et al. | The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging | |
| Waterhouse et al. | Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers | |
| Hiratsuka et al. | Hepato‐entrained B220+ CD11c+ NK1. 1+ cells regulate pre‐metastatic niche formation in the lung | |
| Sobol et al. | Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma | |
| Radu-Cosnita et al. | Anti-chloride intracellular channel protein 1 (CLIC1) antibodies induce tumour necrosis and angiogenesis inhibition on in vivo experimental models of human renal cancer | |
| Ko et al. | The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis | |
| Buumba et al. | A critical review on recent development of techniques and drug targets in the management of breast cancer | |
| Dreicer et al. | A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer | |
| Kawaragi et al. | Teriparatide does not exacerbate bone metastases in breast cancer bone metastasis model | |
| Aung et al. | Osteogenic sarcoma in children and young adults | |
| CN109069632A (zh) | 用于治疗结直肠癌的雷莫芦单抗和merestinib的组合 | |
| Sagus et al. | Uveal melanoma in the first 4 decades of life |